Liv I Bjoner Sikkeland,
Christen P Dahl,
Thor Ueland,
Arne K Andreassen,
Einar Gude,
Thor Edvardsen,
Torbjørn Holm,
Arne Yndestad,
Lars Gullestad,
Johny Kongerud,
Pål Aukrust,
Erik Øie
[show abstract]
[hide abstract]
ABSTRACT: Pathophysiological interactions between heart and lungs in heart failure (HF) are well recognized. We investigated whether expression of different factors known to be increased in the myocardium and/or the circulation in HF is also increased in alveolar macrophages in HF.
Lung function, hemodynamic parameters, gene expression in alveolar macrophages, and plasma levels in the pulmonary and femoral arteries of HF patients (n = 20) were compared to control subjects (n = 16). Our principal findings were: (1) Lung function was significantly lower in HF patients compared to controls (P<0.05). (2) mRNA levels of ET-1, tumor necrosis factor (TNF)-α and interleukin-6 (IL-6) were increased in alveolar macrophages from HF patients. (3) Plasma levels of ET-1, TNFα, IL-6 and MCP-1 were significantly increased in HF patients, whereas our data indicate a net pulmonary release of MCP-1 into the circulation in HF.
Several important cytokines and ET-1 are induced in alveolar macrophages in human HF. Further studies should clarify whether increased synthesis of these factors affects pulmonary remodeling and, directly or indirectly, adversely affects the failing myocardium.
PLoS ONE 01/2012; 7(5):e36815. · 4.09 Impact Factor
